A citation-based method for searching scientific literature

Claude Le Pen, Bernard Bauduceau, Xavier Ansolabehere, Arnaud Troubat, Sébastien Bineau, Mahaut Ripert, Sylvie Dejager. Ann Endocrinol (Paris) 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Rethinking the Appraisal and Approval of Drugs for Fracture Prevention.
Juan Erviti, Javier Gorricho, Luis C Saiz, Thomas Perry, James M Wright. Front Pharmacol 2017
3
100

Comparative Analysis of Medicines Safety Advisories Released by Australia, Canada, the United States, and the United Kingdom.
Lucy T Perry, Alice Bhasale, Alice Fabbri, Joel Lexchin, Lorri Puil, Maisah Joarder, Barbara Mintzes. JAMA Intern Med 2019
14
100


Pharmaceuticals as a market for "lemons": Theory and practice.
Donald W Light, Joel R Lexchin. Soc Sci Med 2021
2
100

Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary.
Emily Reeve, Barbara Farrell, Wade Thompson, Nathan Herrmann, Ingrid Sketris, Parker J Magin, Lynn Chenoweth, Mary Gorman, Lyntara Quirke, Graeme Bethune,[...]. Med J Aust 2019
22
100

Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study.
William Fleischman, Shantanu Agrawal, Marissa King, Arjun K Venkatesh, Harlan M Krumholz, Douglas McKee, Douglas Brown, Joseph S Ross. BMJ 2016
88
100


Is Hemoglobin A1c the Right Outcome for Studies of Diabetes?
Kasia J Lipska, Harlan M Krumholz. JAMA 2017
58
100

Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017.
Helen J Curtis, John M Dennis, Beverley M Shields, Alex J Walker, Seb Bacon, Andrew T Hattersley, Angus G Jones, Ben Goldacre. Diabetes Obes Metab 2018
30
100

Tools for Assessment of the Appropriateness of Prescribing and Association with Patient-Related Outcomes: A Systematic Review.
Nashwa Masnoon, Sepehr Shakib, Lisa Kalisch-Ellett, Gillian E Caughey. Drugs Aging 2018
26
100


Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS.
Elena Tsourdi, Bente Langdahl, Martine Cohen-Solal, Bérengere Aubry-Rozier, Erik Fink Eriksen, Nuria Guañabens, Barbara Obermayer-Pietsch, Stuart H Ralston, Richard Eastell, M Carola Zillikens. Bone 2017
203
100


Assessment of the therapeutic value of new medicines marketed in Australia.
Agnes I Vitry, Ng Huah Shin, Pauline Vitre. J Pharm Policy Pract 2013
7
100

New safety signals assessed by the Pharmacovigilance Risk Assessment Committee at EU level in 2014-2017.
Andrea Farcaş, Andreea Măhălean, Noémi Beátrix Bulik, Daniel Leucuta, Cristina Mogoșan. Expert Rev Clin Pharmacol 2018
7
100


Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis.
Huseyin Naci, Courtney Davis, Jelena Savović, Julian P T Higgins, Jonathan A C Sterne, Bishal Gyawali, Xochitl Romo-Sandoval, Nicola Handley, Christopher M Booth. BMJ 2019
63
100


Trends in adverse drug reaction-related hospitalisations over 13 years in New South Wales, Australia.
Hanwen Zhang, Wei Du, Danijela Gnjidic, Shanley Chong, Nicholas Glasgow. Intern Med J 2019
10
100

The cumulative effect of reporting and citation biases on the apparent efficacy of treatments: the case of depression.
Y A de Vries, A M Roest, P de Jonge, P Cuijpers, M R Munafò, J A Bastiaansen. Psychol Med 2018
22
100


Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes.
Olga Montvida, Jonathan Shaw, John J Atherton, Frances Stringer, Sanjoy K Paul. Diabetes Care 2018
113
100

Raising the bar for market authorisation of new drugs.
Huseyin Naci, Jonathan Cylus, Sotiris Vandoros, Azusa Sato, Kumar Perampaladas. BMJ 2012
19
100



New drugs: where did we go wrong and what can we do better?
Beate Wieseler, Natalie McGauran, Thomas Kaiser. BMJ 2019
41
100

Adverse drug reactions in patients with Alzheimer's disease and related dementia in France: a national multicentre cross-sectional study.
Marie-Laure Laroche, Marie-Christine Perault-Pochat, Isabelle Ingrand, Louis Merle, Carmen Kreft-Jais, Anne Castot-Villepelet, Geneviève Durrieu, Valérie Gras, Claire Guy, Marie-Josèphe Jean-Pastor,[...]. Pharmacoepidemiol Drug Saf 2013
31
100


Olmesartan-associated duodenal villous atrophy, an emerging clinical issue.
Nupur Shukla, Kylies Moore, Genevieve M Gabb. Intern Med J 2020
2
100

Rethinking the appraisal and approval of drugs for type 2 diabetes.
Huseyin Naci, Richard Lehman, Olivier J Wouters, Ben Goldacre, John S Yudkin. BMJ 2015
9
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.